CXCL10 and infection: Further investigation into the mechanism(s) by which CXCL10 exerts its antimicrobial effect against E. coli not only should broaden our current understanding of the pleiotropic role of chemokines in host defense but may also reveal new drug targets that can be utilized to treat infections caused by E. coli or other antibiotic-resistant Gram-negative pathogens.